CYTXW : Summary for Cytori Therapeutics Inc - Yahoo Finance

U.S. Markets open in 5 hrs 48 mins

Cytori Therapeutics Inc (CYTXW)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.69+0.01 (+2.00%)
At close: 3:15PM EDT
People also watch
CBMXWCYCCPGALTWCZWIDHRM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.68
Open0.00
Bid0.01 x 100
Ask9.94 x 100
Day's Range0.63 - 0.69
52 Week Range0.63 - 0.69
Volume300
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press11 hours ago

    Cytori reports 4Q loss

    On a per-share basis, the San Diego-based company said it had a loss of 24 cents. The developer of cell therapies posted revenue of $1.5 million in the period. For the year, the company reported that its ...

  • American City Business Journals2 months ago

    San Diego company to buy stalled San Antonio-based cancer drug developer

    Azaya Therapeutics Inc., a San Antonio-based cancer drug developer, has agreed to sell its assets to Cytori Therapeutics Inc., a specialty pharmaceutical company based in San Diego, in a deal potentially worth $170 million. Under the terms of the agreement, at closing, Cytori (CYTX) will issue $2 million of its common stock and be responsible for about $2 million of Azaya’s trade payables. Azaya Chairman John Kerr said talks with Cytori began last August.

  • MarketWatch2 months ago

    Cytori Therapeutics stock surges 7.9% on agreement to buy assets from Azaya Therapeutics

    Cytori Therapeutics Inc. stock surged 7.9% to $1.78 per share in morning trade Thursday after the company said it had agreed to purchase assets from privately-held Azaya Therapeutics. Under the terms of ...